Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ACVRL1 CL E G H | 94 | 175 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 178 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ADAMTSL1 CL E G H | 92949 | 14632 | ORPHA:521445 | Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome | HP:0040282 - Frequent | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ADCY10 CL E G H | 55811 | 21285 | OMIM:143870 | Hypercalciuria, absorptive, susceptibility to | | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ADCY10 CL E G H | 55811 | 21285 | ORPHA:2197 | Idiopathic hypercalciuria | | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | AGPAT2 CL E G H | 10555 | 325 | OMIM:608594 | Lipodystrophy, congenital generalized, type 1 | . | | | 85 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | AGXT CL E G H | 189 | 341 | OMIM:259900 | Hyperoxaluria, primary, type I | | | | 260 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | AGXT CL E G H | 189 | 341 | ORPHA:93598 | Primary hyperoxaluria type 1 | HP:0040281 - Very frequent | | | 260 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ALG5 CL E G H | 29880 | 20266 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ALG9 CL E G H | 79796 | 15672 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 93 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ANTXR1 CL E G H | 84168 | 21014 | ORPHA:2067 | GAPO syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | AP2S1 CL E G H | 1175 | 565 | OMIM:600740 | Hypocalciuric hypercalcemia, familial, type III | HP:0040283 - Occasional | | | 6 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | . | | | 19 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | HP:0040282 - Frequent | | | 19 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ARMC5 CL E G H | 79798 | 25781 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | HP:0040282 - Frequent | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ARSK CL E G H | 153642 | 25239 | OMIM:619698 | MUCOPOLYSACCHARIDOSIS, TYPE X; MPS10 | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ATP6V1B1 CL E G H | 525 | 853 | OMIM:267300 | Renal tubular acidosis, distal, with progressive nerve deafness | . | | | 67 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | . | | | 315 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BAZ1B CL E G H | 9031 | 961 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BCL7B CL E G H | 9275 | 1005 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BICC1 CL E G H | 80114 | 19351 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:269700 | Lipodystrophy, congenital generalized, type 2 | . | | | 105 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BTNL2 CL E G H | 56244 | 1142 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | BUD23 CL E G H | 114049 | 16405 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CA2 CL E G H | 760 | 1373 | ORPHA:2785 | Osteopetrosis with renal tubular acidosis | | | | 29 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CACNA1D CL E G H | 776 | 1391 | OMIM:615474 | Primary aldosteronism, seizures, and neurologic abnormalities | HP:0040283 - Occasional | | | 51 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CACNA1D CL E G H | 776 | 1391 | ORPHA:369929 | Primary hyperaldosteronism-seizures-neurological abnormalities syndrome | HP:0040283 - Occasional | | | 51 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CAMKMT CL E G H | 79823 | 26276 | ORPHA:163693 | 2p21 microdeletion syndrome | HP:0040281 - Very frequent | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CASR CL E G H | 846 | 1514 | OMIM:601198 | Hypocalcemia, autosomal dominant 1 | | | | 272 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CASR CL E G H | 846 | 1514 | OMIM:145980 | Hypocalciuric hypercalcemia, familial, type I | . | | | 272 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDC73 CL E G H | 79577 | 16783 | OMIM:145001 | Hyperparathyroidism 2 | . | | | 169 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDC73 CL E G H | 79577 | 16783 | ORPHA:99880 | Hyperparathyroidism-jaw tumor syndrome | HP:0040282 - Frequent | | | 169 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDC73 CL E G H | 79577 | 16783 | ORPHA:143 | Parathyroid carcinoma | HP:0040282 - Frequent | | | 169 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDKN1C CL E G H | 1028 | 1786 | OMIM:130650 | Beckwith-Wiedemann syndrome | . | | | 114 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CHKA CL E G H | 1119 | 1937 | OMIM:620023 | | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CHST14 CL E G H | 113189 | 24464 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 27 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLCN5 CL E G H | 1184 | 2023 | OMIM:300009 | Dent disease 1 | | | | 112 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLCN5 CL E G H | 1184 | 2023 | OMIM:300554 | Hypophosphatemic rickets, X-linked recessive | . | | | 112 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLCN5 CL E G H | 1184 | 2023 | OMIM:310468 | Nephrolithiasis, type I | . | | | 112 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | | | | 3 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | . | | | 58 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLDN19 CL E G H | 149461 | 2040 | ORPHA:2196 | Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement | HP:0040281 - Very frequent | | | 42 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLDN19 CL E G H | 149461 | 2040 | OMIM:248190 | Hypomagnesemia 5, renal, with or without ocular involvement | . | | | 42 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLDN2 CL E G H | 9075 | 2041 | OMIM:301060 | AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS; OAZON | | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CLIP2 CL E G H | 7461 | 2586 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | COQ6 CL E G H | 51004 | 20233 | OMIM:614650 | Coenzyme Q10 deficiency, primary, 6 | | | | 39 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion | HP:0040283 - Occasional | | | 291 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353277 | Rubinstein-Taybi syndrome due to CREBBP mutations | HP:0040283 - Occasional | | | 291 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CTH CL E G H | 1491 | 2501 | ORPHA:212 | Cystathioninuria | HP:0040283 - Occasional | | | 38 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | . | | | 178 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | HP:0040283 - Occasional | | | 73 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | DNAJB11 CL E G H | 51726 | 14889 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | DNAJC30 CL E G H | 84277 | 16410 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | DSE CL E G H | 29940 | 21144 | ORPHA:2953 | Musculocontractural Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 13 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | EIF4H CL E G H | 7458 | 12741 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ELN CL E G H | 2006 | 3327 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 172 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ENG CL E G H | 2022 | 3349 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 186 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | EP300 CL E G H | 2033 | 3373 | ORPHA:353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | HP:0040283 - Occasional | | | 250 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | FBN1 CL E G H | 2200 | 3603 | ORPHA:2833 | Stiff skin syndrome | HP:0040283 - Occasional | | | 1361 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | FKBP6 CL E G H | 8468 | 3722 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | . | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GANAB CL E G H | 23193 | 4138 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 6 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GCM2 CL E G H | 9247 | 4198 | OMIM:617343 | Hyperparathyroidism 4 | HP:0040283 - Occasional | | | 51 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GDF2 CL E G H | 2658 | 4217 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 8 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GNA11 CL E G H | 2767 | 4379 | OMIM:145981 | Hypocalciuric hypercalcemia, familial, type II | HP:0040283 - Occasional | | | 16 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:189427 | Cushing syndrome due to macronodular adrenal hyperplasia | HP:0040282 - Frequent | | | 101 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GRHPR CL E G H | 9380 | 4570 | OMIM:260000 | Hyperoxaluria, primary, type II | | | | 70 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GRHPR CL E G H | 9380 | 4570 | ORPHA:93599 | Primary hyperoxaluria type 2 | HP:0040281 - Very frequent | | | 70 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GTF2I CL E G H | 2969 | 4659 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GTF2IRD1 CL E G H | 9569 | 4661 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | GTF2IRD2 CL E G H | 84163 | 30775 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | H19-ICR CL E G H | 105259599 | | OMIM:130650 | Beckwith-Wiedemann syndrome | . | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HGD CL E G H | 3081 | 4892 | OMIM:203500 | Alkaptonuria | | | | 77 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HGD CL E G H | 3081 | 4892 | ORPHA:56 | Alkaptonuria | HP:0040282 - Frequent | | | 77 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:797 | Sarcoidosis | HP:0040283 - Occasional | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HNF1B CL E G H | 6928 | 11630 | ORPHA:1309 | Medullary sponge kidney | HP:0040281 - Very frequent | | | 90 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HNF1B CL E G H | 6928 | 11630 | OMIM:137920 | Renal cysts and diabetes syndrome | . | | | 90 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HOGA1 CL E G H | 112817 | 25155 | OMIM:613616 | HYPEROXALURIA, PRIMARY, TYPE III; HP3 | | | | 83 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HOGA1 CL E G H | 112817 | 25155 | ORPHA:93600 | Primary hyperoxaluria type 3 | | | | 83 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300323 | Gout, hprt-related | . | | | 76 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:79233 | Hypoxanthine guanine phosphoribosyltransferase partial deficiency | | | | 76 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300322 | Lesch-Nyhan syndrome | . | | | 76 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | HSPG2 CL E G H | 3339 | 5273 | ORPHA:800 | Schwartz-Jampel syndrome | HP:0040283 - Occasional | | | 345 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | IFT140 CL E G H | 9742 | 29077 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 148 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | IGF2 CL E G H | 3481 | 5466 | OMIM:130650 | Beckwith-Wiedemann syndrome | . | | | 9 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | KCNH1 CL E G H | 3756 | 6250 | OMIM:135500 | Zimmermann-Laband syndrome 1 | HP:0040283 - Occasional | | | 13 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | KCNQ1 CL E G H | 3784 | 6294 | OMIM:130650 | Beckwith-Wiedemann syndrome | . | | | 730 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | KCNQ1OT1 CL E G H | 10984 | 6295 | OMIM:130650 | Beckwith-Wiedemann syndrome | . | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | KRT17 CL E G H | 3872 | 6427 | ORPHA:841 | Sebocystomatosis | HP:0040283 - Occasional | | | 23 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | LIMK1 CL E G H | 3984 | 6613 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | METTL27 CL E G H | 155368 | 19068 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MGME1 CL E G H | 92667 | 16205 | ORPHA:352447 | Progressive external ophthalmoplegia-myopathy-emaciation syndrome | HP:0040283 - Occasional | | | 11 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MLXIPL CL E G H | 51085 | 12744 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | HP:0040283 - Occasional | | | 4 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MOCS1 CL E G H | 4337 | 7190 | OMIM:252150 | Molybdenum cofactor deficiency, complementation group A | | | | 96 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MOCS2 CL E G H | 4338 | 7193 | OMIM:252160 | Molybdenum cofactor deficiency, complementation group B | | | | 26 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | MYL9 CL E G H | 10398 | 15754 | OMIM:619365 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4 | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | NCF1 CL E G H | 653361 | 7660 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | 13 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | NHERF1 CL E G H | 9368 | 11075 | OMIM:612287 | Nephrolithiasis/osteoporosis, hypophosphatemic, 2 | . | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | NOD2 CL E G H | 64127 | 5331 | OMIM:617321 | YAO SYNDROME; YAOS | | | | 187 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | OCRL CL E G H | 4952 | 8108 | ORPHA:534 | Oculocerebrorenal syndrome of Lowe | HP:0040283 - Occasional | | | 88 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | OPLAH CL E G H | 26873 | 8149 | OMIM:260005 | 5-@oxoprolinase deficiency | | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PAX2 CL E G H | 5076 | 8616 | OMIM:120330 | Papillorenal syndrome | HP:0040283 - Occasional | | | 39 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PDE11A CL E G H | 50940 | 8773 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 13 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PDE8B CL E G H | 8622 | 8794 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 75 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PIDD1 CL E G H | 55367 | 16491 | OMIM:619827 | INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75 | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PKD1 CL E G H | 5310 | 9008 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 342 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PKD2 CL E G H | 5311 | 9009 | ORPHA:730 | Autosomal dominant polycystic kidney disease | HP:0040283 - Occasional | | | 106 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PLCD1 CL E G H | 5333 | 9060 | ORPHA:2387 | Leukonychia totalis | HP:0040281 - Very frequent | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PLG CL E G H | 5340 | 9071 | ORPHA:722 | Hypoplasminogenemia | HP:0040283 - Occasional | | | 11 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PLG CL E G H | 5340 | 9071 | OMIM:217090 | Plasminogen deficiency, type iligneous conjunctivitis, included | . | | | 11 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PPM1B CL E G H | 5495 | 9276 | ORPHA:163693 | 2p21 microdeletion syndrome | HP:0040281 - Very frequent | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PREPL CL E G H | 9581 | 30228 | ORPHA:163693 | 2p21 microdeletion syndrome | HP:0040281 - Very frequent | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PREPL CL E G H | 9581 | 30228 | ORPHA:163690 | Hypotonia-cystinuria syndrome | HP:0040281 - Very frequent | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PRKACA CL E G H | 5566 | 9380 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:189439 | Primary pigmented nodular adrenocortical disease | | | | 134 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411536 | Mild phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PRPS1 CL E G H | 5631 | 9462 | OMIM:300661 | Phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411543 | Severe phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | RFC2 CL E G H | 5982 | 9970 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | ROR2 CL E G H | 4920 | 10257 | OMIM:268310 | Robinow syndrome, autosomal recessive | | | | 120 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SERPINH1 CL E G H | 871 | 1546 | OMIM:613848 | Osteogenesis imperfecta, type X | . | | | 52 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SETBP1 CL E G H | 26040 | 15573 | ORPHA:798 | Schinzel-Giedion syndrome | HP:0040284 - Very rare | | | 143 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SI CL E G H | 6476 | 10856 | OMIM:222900 | Sucrase-isomaltase deficiency, congenital | . | | | 98 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC1A1 CL E G H | 6505 | 10939 | OMIM:222730 | Dicarboxylicamino aciduria | | | | 71 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC22A12 CL E G H | 116085 | 17989 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 56 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC26A1 CL E G H | 10861 | 10993 | OMIM:167030 | Nephrolithiasis, calcium oxalate | | | | 24 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC2A9 CL E G H | 56606 | 13446 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 57 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC2A9 CL E G H | 56606 | 13446 | OMIM:612076 | Hypouricemia, renal, 2 | HP:0040283 - Occasional | | | 57 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:157215 | Hereditary hypophosphatemic rickets with hypercalciuria | HP:0040282 - Frequent | | | 47 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC34A1 CL E G H | 6569 | 11019 | OMIM:612286 | Nephrolithiasis/osteoporosis, hypophosphatemic, 1 | . | | | 47 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC34A2 CL E G H | 10568 | 11020 | ORPHA:60025 | Pulmonary alveolar microlithiasis | | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC34A3 CL E G H | 142680 | 20305 | ORPHA:157215 | Hereditary hypophosphatemic rickets with hypercalciuria | HP:0040282 - Frequent | | | 52 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC34A3 CL E G H | 142680 | 20305 | OMIM:241530 | Hypophosphatemic rickets with hypercalciuria, hereditary | | | | 52 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC36A2 CL E G H | 153201 | 18762 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 2 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040283 - Occasional | | | 110 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | . | | | 110 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC3A1 CL E G H | 6519 | 11025 | ORPHA:163693 | 2p21 microdeletion syndrome | HP:0040281 - Very frequent | | | 55 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC3A1 CL E G H | 6519 | 11025 | OMIM:220100 | CYSTINURIA | . | | | 55 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC3A1 CL E G H | 6519 | 11025 | ORPHA:163690 | Hypotonia-cystinuria syndrome | HP:0040281 - Very frequent | | | 55 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC4A1 CL E G H | 6521 | 11027 | OMIM:179800 | Renal tubular acidosis, distal, autosomal dominant | | | | 109 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC5A1 CL E G H | 6523 | 11036 | ORPHA:35710 | Glucose-galactose malabsorption | HP:0040283 - Occasional | | | 74 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC6A19 CL E G H | 340024 | 27960 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 12 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC6A20 CL E G H | 54716 | 30927 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 96 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC7A9 CL E G H | 11136 | 11067 | OMIM:220100 | CYSTINURIA | . | | | 58 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SMAD4 CL E G H | 4089 | 6770 | ORPHA:774 | Hereditary hemorrhagic telangiectasia | HP:0040283 - Occasional | | | 504 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | SPRED1 CL E G H | 161742 | 20249 | ORPHA:137605 | Legius syndrome | | | | 136 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | TBL2 CL E G H | 26608 | 11586 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | TMEM270 CL E G H | 135886 | 23018 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | VDR CL E G H | 7421 | 12679 | ORPHA:93160 | Hypocalcemic vitamin D-resistant rickets | HP:0040282 - Frequent | | | 104 | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | VPS37D CL E G H | 155382 | 18287 | ORPHA:904 | Williams syndrome | HP:0040283 - Occasional | | | | | |
HP:0000787 | HP:0000787 | Nephrolithiasis | 0 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | | | | 79 | | |
HP:0000787 | HP:0033591 | Staghorn calculus | 1 | CL E G H | | | | | | | | | | |
HP:0000787 | HP:0030035 | Struvite nephrolithiasis | 1 | CL E G H | | | | | | | | | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | ADCY10 CL E G H | 55811 | 21285 | OMIM:143870 | Hypercalciuria, absorptive, susceptibility to | | | | 5 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | ADCY10 CL E G H | 55811 | 21285 | ORPHA:2197 | Idiopathic hypercalciuria | | | | 5 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | AGXT CL E G H | 189 | 341 | OMIM:259900 | Hyperoxaluria, primary, type I | | | | 260 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | HP:0040283 - Occasional | | | 19 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | GRHPR CL E G H | 9380 | 4570 | OMIM:260000 | Hyperoxaluria, primary, type II | | | | 70 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | HOGA1 CL E G H | 112817 | 25155 | OMIM:613616 | HYPEROXALURIA, PRIMARY, TYPE III; HP3 | | | | 83 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | HOGA1 CL E G H | 112817 | 25155 | ORPHA:93600 | Primary hyperoxaluria type 3 | | | | 83 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:79233 | Hypoxanthine guanine phosphoribosyltransferase partial deficiency | HP:0040283 - Occasional | | | 76 | | |
HP:0000787 | HP:0000804 | Xanthine nephrolithiasis | 1 | MOCS1 CL E G H | 4337 | 7190 | OMIM:252150 | Molybdenum cofactor deficiency, complementation group A | . | | | 96 | | |
HP:0000787 | HP:0000804 | Xanthine nephrolithiasis | 1 | MOCS2 CL E G H | 4338 | 7193 | OMIM:252160 | Molybdenum cofactor deficiency, complementation group B | . | | | 26 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | OPLAH CL E G H | 26873 | 8149 | OMIM:260005 | 5-@oxoprolinase deficiency | | | | 5 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411536 | Mild phosphoribosylpyrophosphate synthetase superactivity | HP:0040282 - Frequent | | | 49 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | PRPS1 CL E G H | 5631 | 9462 | OMIM:300661 | Phosphoribosylpyrophosphate synthetase superactivity | . | | | 49 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411543 | Severe phosphoribosylpyrophosphate synthetase superactivity | HP:0040281 - Very frequent | | | 49 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | SLC22A12 CL E G H | 116085 | 17989 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 56 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | . | | | 56 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC26A1 CL E G H | 10861 | 10993 | OMIM:167030 | Nephrolithiasis, calcium oxalate | | | | 24 | | |
HP:0000787 | HP:0000791 | Uric acid nephrolithiasis | 1 | SLC2A9 CL E G H | 56606 | 13446 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 57 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC34A2 CL E G H | 10568 | 11020 | ORPHA:60025 | Pulmonary alveolar microlithiasis | HP:0040284 - Very rare | | | 7 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC34A3 CL E G H | 142680 | 20305 | OMIM:241530 | Hypophosphatemic rickets with hypercalciuria, hereditary | . | | | 52 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC36A2 CL E G H | 153201 | 18762 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 2 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC6A19 CL E G H | 340024 | 27960 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 12 | | |
HP:0000787 | HP:0004724 | Calcium nephrolithiasis | 1 | SLC6A20 CL E G H | 54716 | 30927 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | | | | 96 | | |
HP:0000787 | HP:0000804 | Xanthine nephrolithiasis | 1 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | . | | | 79 | | |
HP:0000787 | HP:0012580 | Calcium phosphate nephrolithiasis | 2 | CL E G H | | | | | | | | | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | ADCY10 CL E G H | 55811 | 21285 | OMIM:143870 | Hypercalciuria, absorptive, susceptibility to | . | | | 5 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | ADCY10 CL E G H | 55811 | 21285 | ORPHA:2197 | Idiopathic hypercalciuria | HP:0040282 - Frequent | | | 5 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | AGXT CL E G H | 189 | 341 | OMIM:259900 | Hyperoxaluria, primary, type I | . | | | 260 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | GRHPR CL E G H | 9380 | 4570 | OMIM:260000 | Hyperoxaluria, primary, type II | . | | | 70 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | HOGA1 CL E G H | 112817 | 25155 | OMIM:613616 | HYPEROXALURIA, PRIMARY, TYPE III; HP3 | | | | 83 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | HOGA1 CL E G H | 112817 | 25155 | ORPHA:93600 | Primary hyperoxaluria type 3 | HP:0040281 - Very frequent | | | 83 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | OPLAH CL E G H | 26873 | 8149 | OMIM:260005 | 5-@oxoprolinase deficiency | . | | | 5 | | |
HP:0000787 | HP:0008651 | Uric acid urolithiasis independent of gout | 2 | SLC22A12 CL E G H | 116085 | 17989 | ORPHA:94088 | Hereditary renal hypouricemia | HP:0040282 - Frequent | | | 56 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | SLC26A1 CL E G H | 10861 | 10993 | OMIM:167030 | Nephrolithiasis, calcium oxalate | . | | | 24 | | |
HP:0000787 | HP:0008651 | Uric acid urolithiasis independent of gout | 2 | SLC2A9 CL E G H | 56606 | 13446 | ORPHA:94088 | Hereditary renal hypouricemia | HP:0040282 - Frequent | | | 57 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | SLC36A2 CL E G H | 153201 | 18762 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | . | | | 2 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | SLC6A19 CL E G H | 340024 | 27960 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | . | | | 12 | | |
HP:0000787 | HP:0008672 | Calcium oxalate nephrolithiasis | 2 | SLC6A20 CL E G H | 54716 | 30927 | OMIM:138500 | Glycinuria with or without oxalate urolithiasis | . | | | 96 | | |